Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?

被引：0
|
作者：
Felicetto Ferrara
机构：
[1] Cardarelli Hospital,Division of Hematology
来源：
Blood Cancer Journal | / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy
    Laloi, Louise
    Billotey, Natacha Chaumard
    Dumas, Pierre-Yves
    Paul, Franciane
    Villate, Alban
    Simand, Celestine
    Fornecker, Luc
    Puisset, Florent
    Bertoli, Sarah
    Simonet, Marion Boissard
    Laribi, Kamel
    Houyou, Dyhia
    Santagostino, Alberto
    Michel, Claire
    Guepin, Gabrielle Roth
    Guerineau, Elodie
    Tabrizi, Reza
    Hunault, Mathilde
    Giltat, Aurelien
    Kaphan, Eleonore
    Bulabois, Claude
    Cartet, Elodie
    Rocher, Clement
    Lachenal, Florence
    Morisset, Stephane
    Recher, Christian
    Pigneux, Arnaud
    Belhabri, Amine
    Michallet, Mauricette
    Michallet, Anne-Sophie
    [J]. CANCER MEDICINE, 2023, 12 (06): : 7175 - 7181
  • [42] Hypomethylating Agents in Combination with Venetoclax As a Bridge to Allogeneic Transplant in Acute Myeloid Leukemia
    Kennedy, Vanessa E.
    Hui, Gavin
    Gaut, Daria
    Mittal, Varun
    Oliai, Caspian
    Muffly, Lori S.
    Logan, Aaron C.
    Mannis, Gabriel N.
    [J]. BLOOD, 2020, 136
  • [43] Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia
    Kennedy, Vanessa E.
    Hui, Gavin
    Azenkot, Tali
    Gaut, Daria
    Wieduwilt, Matthew J.
    Oliai, Caspian
    Jonas, Brian A.
    Mittal, Varun
    Logan, Aaron C.
    Muffly, Lori S.
    Mannis, Gabriel N.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : E191 - E194
  • [44] Venetoclax and hypomethylating agents inFLT3-mutated acute myeloid leukemia
    Aldoss, Ibrahim
    Zhang, Jianying
    Mei, Matthew
    Al Malki, Monzr M.
    Arslan, Shukaib
    Ngo, Dat
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Salhotra, Amandeep
    Koller, Paul
    Khaled, Samer
    Artz, Andrew
    Snyder, David
    Nakamura, Ryotaro
    Forman, Stephen J.
    Stein, Anthony S.
    Marcucci, Guido
    Pullarkat, Vinod
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (10) : 1193 - 1199
  • [45] Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
    Aldoss, Ibrahim
    Yang, Dongyun
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Al Malki, Monzr M.
    Mei, Matthew
    Salhotra, Amandeep
    Khaled, Samer
    Nakamura, Ryotaro
    Snyder, David
    O'Donnell, Margaret
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    [J]. HAEMATOLOGICA, 2018, 103 (09) : E404 - E407
  • [46] Inpatient Versus Outpatient Administration of Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia
    Sanka, Pranavi
    Egan, Pamela
    Niroula, Rabin
    Yakirevich, Inna
    Gardner, David
    Reagan, John L.
    [J]. BLOOD, 2023, 142
  • [47] Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents
    Aldoss, Ibrahim
    Dadwal, Sanjeet
    Zhang, Jianying
    Tegtmeier, Bernard
    Mei, Matthew
    Arslan, Shukaib
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Ali, Haris
    Aribi, Ahmed
    Sandhu, Karamjeet
    Khaled, Samer
    Snyder, David
    Nakamura, Ryotaro
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    [J]. BLOOD ADVANCES, 2019, 3 (23) : 4043 - 4049
  • [48] More options for older patients with acute myeloid leukemia: venetoclax in combination with low dose cytarabine
    Aldoss, Ibrahim
    Marcucci, Guido
    [J]. CHINESE CLINICAL ONCOLOGY, 2019, 8
  • [49] Retrospective Analysis of Adults with Acute Myeloid Leukemia Treated with Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center
    Tenold, Matthew
    Moskoff, Benjamin
    Benjamin, David
    Jonas, Brian A.
    [J]. BLOOD, 2018, 132
  • [50] Venetoclax Plus Hypomethylating Agents for Relapsed/Refractory Acute Myeloid Leukemia (AML) Is Safe and Manageable in the Outpatient Setting
    Nanni, Jacopo
    Papayannidis, Cristina
    Cristiano, Gianluca
    Marconi, Giovanni
    Sartor, Chiara
    Parisi, Sarah
    Ottaviani, Emanuela
    Baldini, Lorenza
    Testoni, Nicoletta
    Baldazzi, Carmen
    Ricci, Paolo
    Bezzi, Chiara Di Giovanni
    Abd-alatif, Rania
    Paolini, Stefania
    Cavo, Michele
    Curti, Antonio
    [J]. BLOOD, 2020, 136
12345